Fatigue in MS and its link to inflammation
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at how fatigue in multiple sclerosis (MS) relates to signs of inflammation and nerve damage. It may help understand why fatigue happens and improve treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with multiple sclerosis (MS) using the latest criteria.
- Your doctor has recommended or you are on a disease-modifying treatment for MS.
- You do not have other major health conditions (multimorbidities).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a safe, non-invasive brain stimulation technique to see if it can reduce fatigue in people with relapsing-remitting MS. It compares people with and without fatigue to understand how the brain is affected.
This trial studies whether giving immunoglobulins (antibody medicines) can improve fatigue in people with multiple sclerosis (MS). It will enroll only people whose MS and fatigue are stable and meet specific blood/health criteria.
This study looks at how multiple sclerosis (MS) affects your thinking, sleep, and tiredness. It compares people with MS who have at least mild fatigue to people without MS who also have sleep problems, to understand these issues better.
This study is investigating fatigue using digital outcomes in people with multiple sclerosis, long COVID, and healthy volunteers. Participants must own a smartphone, be fluent in German or English, and be willing to provide informed consent. Exclusion criteria include having taken certain medications recently, being pregnant or lactating, or having additional health conditions that could affect fatigue or the autonomic nervous system.
This trial tests an online self-management program to help reduce fatigue in people with MS. You'll use a website or app over 24 weeks, and researchers will check how well it works.
This study tests two non-invasive brain stimulation treatments—TMS and tDCS—to see if they can reduce fatigue in people with relapsing-remitting MS. The goal is to find a safe, drug-free way to help you feel less tired.
Hear when a new Fatigue in Multiple Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.